Search

Byline: Natasha May Health reporter More than 100 pregnant women have been exposed to medication for epilepsy and bipolar disorder which carries a high risk of birth defects, as the [...]

WILMINGTON, Del: NRx Pharmaceuticals, Inc. has issued the following news release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx', the 'Company'), a clinical-stage biopharmaceutical company, today announced the transmission of first section [...]

More than half a million patients face shortages of vital medications as Britain is hit by a crisis in the supply of drugs, The Independent has been told. The NHS [...]

ATLANTA: ALZAMEND NEURO, INC. has issued the following news release: Alzamend Neuro, Inc. (Nasdaq: ALZN) ('Alzamend'), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's [...]

GAITHERSBURG: announced significant advancements in its ongoing collaboration with the Lieber Institute for Brain Development. Building on the progress detailed in our May 16, 2024 release, our research has now [...]

PHILADELPHIA, PA -- The following information was released by the University of Pennsylvania School of Medicine: Potential therapy can be completed in five days of treatment, compared to 4-6 weeks [...]

RADNOR, Pa: NRx Pharmaceuticals, Inc has issued the following press release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', the 'Company'), a clinical-stage biopharmaceutical company, today announced that advice from regulatory [...]

LAFAYETTE, Calif., May 31, 2024 /PRNewswire/ -- The Alexander Shulgin Research Institute (ASRI) has unveiled a groundbreaking discovery in the journal Molecular Pharmacology: the first bifunctional compound that acts as [...]

RADNOR, Pa: NRx Pharmaceuticals, Inc. has issued the following news release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', 'NRx', the 'Company'), a clinical stage pharmaceutical company, today announced presentation of [...]

RADNOR, Pa: NRx Pharmaceuticals has issued the following news release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', the 'Company'), a clinical stage pharmaceutical company today that its Breakthrough Therapy designated [...]

NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia relative to [...]

FALLS CHURCH: Response Pharmaceuticals, Inc., a clinical stage company focused on weight management and metabolic health in high-risk populations, announced positive topline results from its Phase 1b clinical trial evaluating [...]

Tuesday, the FDA approved Vanda Pharmaceuticals Inc's VNDA Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Fanapt is an [...]

WASHINGTON: Vanda Pharmaceuticals Inc. has issued the following news release: Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Fanapt(r) (iloperidone) [...]

Fanapt Treatment is Now Available to Adult Patients for the Acute Treatment of Manic or Mixed Episodes Associated with Bipolar I Disorder Approval Represents Significant Novel Indication for Vanda's Fanapt [...]

MINNEAPOLIS: ADVANCED BRAIN + BODY CLINIC KETAMINE TMS has issued the following news release: Advanced Brain + Body Clinic Ketamine TMS (AB+BC), specialists in treatment-resistant depression and other severe mental [...]

RADNOR: NRx Pharmaceuticals, Inc. has issued the following news release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', the 'Company'), a clinical-stage biopharmaceutical company, announced that the 74th and last evaluable [...]

ST. PAUL, Minn. -- The following information was released by the Minnesota House of Representatives: By Miranda Bryant More treatment and support services for youth and adults up to age [...]

Baszucki Group has partnered with McLean Hospital in Belmont, MA, to conduct a clinical trial of a therapeutic ketogenic diet for bipolar disorder. The cross-disciplinary team will investigate nutritional ketosis [...]

Byline: By, Lauren Gordon Kim Kardashian pleaded with her ex-husband Kanye West to resume his medication in a leaked clip from a 2018 documentary about the rapper. In the clip, [...]

Exceeded originally target enrollment (70) with n=74 Last patient, last visit expected in approximately six weeks; data to follow shortly thereafter Positive data triggers milestone payment from Alvogen, as previously [...]

WASHINGTON: Vanda Pharmaceuticals Inc. has issued the following news release: Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled 'Efficacy and Safety of Iloperidone in [...]

WASHINGTON, Jan. 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled 'Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, [...]

BALTIMORE, Dec. 6, 2023 /PRNewswire/ -- JAMA Psychiatry recently published a first-of-its-kind https://c212.net/c/link/?t=0&l=en&o=4044087-1&h=1840290589&u=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjamapsychiatry%2Ffullarticle%2F2812443&a=clinical+trial conducted at Sheppard Pratt studying the efficacy and safety of a single dose of synthetic psilocybin accompanied [...]

ATLANTA: Alzamend Neuro, Inc. (Alzamend), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder, major depressive disorder and post-traumatic stress disorder, [...]

Chicago: IV Solution & Ketamine Centers of Chicago has issued the following news release: IV Solution & Ketamine Centers of Chicago, Chicago's first private facility to offer clinically proven intravenous [...]

ATLANTA: Alzamend Neuro, Inc. has issued the following news release: Alzamend Neuro, Inc. (Nasdaq: ALZN) ('Alzamend'), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's [...]

Covina: PMI has issued the following news release: The antipsychotics market is a segment of the pharmaceutical industry focused on the development, manufacturing, and distribution of medications known as antipsychotic [...]

Byline: By, Lucy Domachowski Kerry Katona has revealed that Phillip Schofield apologised to her after her infamous This Morning interview from 10 years ago when she was heard slurring her [...]

ATLANTA: Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease bipolar disorder ('BD'), major depressive disorder ('MDD') and post-traumatic stress disorder [...]

NEWARK: The global psychotropic drugs market size is US$ 21,269.4 million in 2023. The market is expected to reach up to US$ 28,876.2 million by 2033. The global market is [...]

ATLANTA: Alzamend Neuro, Inc., ('Alzamend') a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ('Alzheimer's'), bipolar disorder ('BD'), major depressive disorder ('MDD') and post-traumatic [...]

Brigham and Women's Hospital-McLean Hospital, University of California Los Angeles, Johns Hopkins University, Mayo Clinic, University of Michigan, and UTHealth Houston are first sites in the BDÙ Integrated Network WASHINGTON, [...]

Alzamend Neuro Inc ALZN has submitted a New Drug Application (IND) to the FDA to initiate AL001-BD01, a Phase 2A study of AL001 for bipolar disorder. Lithium is a commonly [...]

NEW HAVEN: BioXcel Therapeutics has issued the following news release: BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, [...]

PRINCETON: Otsuka America Pharmaceutical, Inc., and Lundbeck have announced the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ABILIFY ASIMTUFII(r) (aripiprazole) extended-release injectable suspension [...]

RADNOR: NRx Pharmaceuticals, Inc. has issued the following news release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', the 'Company'), a clinical-stage CNS biopharmaceutical company, today reported that the independent Data [...]

- The independent Data Safety Monitoring Board recommended continuation of patient enrollment as planned - No safety or futility signals were reported in the first 50 patients - This patient [...]

ATLANTA: Alzamend Neuro, Inc. (Nasdaq: ALZN) (Alzamend), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder, major depressive disorder (MDD) [...]

Pune India: GreyViews has issued the following news release: The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the [...]

Rykindo is a bi-weekly long-acting risperidone injection and is the first innovative therapy from Luye Pharma's Central Nervous System (CNS) product portfolio to be marketed in the United States. PRINCETON, [...]

WASHINGTON: Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported positive results in a Phase III clinical study of Fanapt(r) (iloperidone tablets), a novel atypical antipsychotic, in the treatment of acute [...]

FDA approved AbbVie Inc. ABBV Vraylar (cariprazine) as adjunctive therapy to antidepressants for major depressive disorder (MDD) in adults. This additional indication, supported by clinical data demonstrating efficacy and well-established [...]

Supplemental New Drug Application (sNDA) planned for 2023 WASHINGTON, Dec. 19, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported positive results in a Phase III clinical study [...]

- Approval marks fourth indication for VRAYLAR, backed by proven efficacy and well-established tolerability as an adjunctive treatment for major depressive disorder (MDD) with an antidepressant therapy (ADT), showing improvement [...]

RADNOR: NRx Pharmaceuticals, Inc. has issued the following news release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ('NRx Pharmaceuticals' or the 'Company'), a clinical-stage CNS biopharmaceutical company, today announced the release of [...]

Manufacturing files submitted to U.S. Food and Drug Administration The company has now completed its transition to U.S.-based manufacturing NRX-101 is now manufactured via a commercial-stage process RADNOR, Pa., Nov. [...]